What are the Lights criteria (Light's criteria) for differentiating between transudative and exudative pleural effusions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Light's Criteria for Pleural Effusion Classification

A pleural effusion is classified as an exudate if it meets at least one of the following three criteria: pleural fluid to serum protein ratio >0.5, pleural fluid to serum LDH ratio >0.6, or pleural fluid LDH >0.67 of the upper limit of normal serum value. 1

The Three Criteria

Light's criteria require simultaneous measurement of both pleural fluid and serum samples for the following parameters:

  • Pleural fluid to serum protein ratio >0.5 1
  • Pleural fluid to serum LDH ratio >0.6 1
  • Pleural fluid LDH >0.67 (or 67%) of the upper limit of normal serum LDH 1

Meeting any single criterion classifies the effusion as exudative. 1

Performance Characteristics

Light's criteria demonstrate excellent sensitivity (98%) but lower specificity (72%) for identifying exudative effusions. 1, 2 This translates to a positive likelihood ratio of 3.5 and a negative likelihood ratio of 0.03. 1, 2

The criteria were deliberately designed to maximize detection of exudates to avoid missing potentially serious conditions such as malignancy or infection. 1 This design philosophy explains why the specificity is intentionally lower—the goal is to err on the side of caution by over-identifying exudates rather than missing them. 1

Critical Pitfall: Pseudoexudates

The most important limitation is that Light's criteria misclassify approximately 25-30% of transudates (particularly from heart failure and cirrhosis) as exudates, creating "pseudoexudates." 1, 3, 4 This occurs most commonly in patients on diuretics. 4

How to Identify and Correct Pseudoexudates

When Light's criteria suggest an exudate but clinical suspicion is high for heart failure or liver disease, use these corrective measures:

  • Serum-pleural fluid albumin gradient >1.2 g/dL correctly reclassifies approximately 80% of pseudoexudates as transudates. 5, 3
  • Pleural fluid to serum albumin ratio <0.6 confirms hepatic hydrothorax when Light's criteria are ambiguous. 1
  • NT-proBNP >1500 μg/mL (in either pleural fluid or serum) identifies heart failure with 92-94% sensitivity and 88-91% specificity. 5, 3

Alternative Approach When Serum Unavailable

If serum samples cannot be obtained, use pleural fluid LDH >67% of the upper limit of normal OR pleural fluid cholesterol >55 mg/dL—this combination has discriminative capacity equivalent to Light's criteria. 1, 3

Clinical Application Algorithm

  1. Obtain simultaneous pleural fluid and serum samples for protein and LDH measurement 1

  2. Apply Light's criteria: If any one criterion is met, classify as exudate 1

  3. If exudate is identified but clinical picture suggests heart failure or cirrhosis (especially if patient is on diuretics):

    • Calculate serum-pleural fluid albumin gradient 5, 3
    • If gradient >1.2 g/dL, reclassify as transudate 5, 3
    • Consider NT-proBNP measurement if heart failure suspected 5, 3
  4. If transudate confirmed: Treat underlying heart failure or cirrhosis; further invasive testing usually unnecessary 1

  5. If exudate confirmed: Proceed with additional diagnostic workup for pneumonia, malignancy, tuberculosis, or pulmonary embolism 1, 6

Additional Caveats

Be aware that different laboratory analyzers can produce discordant results in up to 18% of cases, particularly affecting LDH measurements in pleural fluid. 7 This analytical variability is most problematic when pleural fluid protein is in the borderline range of 25-35 g/L. 7

Some conditions can produce either transudates or exudates (such as non-expansile lung, chylothorax, and superior vena cava syndrome), so classification alone does not always indicate specific etiology. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Classification of Pleural Effusions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diferenciación entre Exudado y Pseudoexudado

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria for Pleural Effusions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnostic approach to pleural effusion in adults.

American family physician, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.